Antenatal and postnatal screening is when a variety of techniques are used to monitor the health of the mother, developing foetus and baby.
Pregnant women are given two ultrasound scans.
Dating scan – takes place between 8 and 14 weeks. It determines the stage of pregnancy and due date. This is used with tests for marker chemicals which vary normally during pregnancy.
Anomaly scan – takes place between 18-20 weeks and may detect serious physicalabnormalities in the foetus.
Routine blood and urine tests are carried out to monitor the concentrations of marker chemicals.
Measuring a chemical at the wrong time could lead to a false positive result.
An atypical chemical concentration can lead to further diagnostic testing to determine if the foetus has a medical condition.
Amniocentesis is a procedure is usually carried out between the 15th and 20th week of pregnancy which involves the collection of foetal cells contained within amniotic fluid.
A needle is inserted through the abdomen/uterus wall into the amniotic sac and a sample of the amniotic fluid is collected.
Amniocentesis:
Advantage – it is used to detect genetic or chromosomalabnormalities of the foetus.
Disadvantage - the procedure carries a risk of miscarriage.
Chorionic villus sampling (CVS) is procedure usually carried out between the 11th and 14th week of pregnancy.
This procedure removes a small sample of cells from the placenta. These can be obtained through the abdomen or through the cervix.
CVS:
Advantage – it is used to detect genetic or chromosomal abnormalities of the foetus and can be performed earlier than an amniocentesis.
Disadvantage - the procedure carries a higher risk of miscarriage than an amniocentesis.
Diagnostic testing:
Cells from samples are cultured to obtain sufficient cells to produce a karyotype to diagnose a range of conditions.